Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: imdxinc.com (IMDX)
The investment potential of Insight Molecular Diagnostics (IMDX) is based on the creation of affordable and rapid precision tests for the mass market. The quarterly EPS change scale visualizes this trend, where -0.70 indicates the current level. Efficiency is confirmed by the integration of software and test systems into a single ecosystem, as well as strict compliance with environmental regulations regarding the disposal of chemical waste.
Ringkesan rincian data analitis Insight Molecular Diagnostics (IMDX)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Insight Molecular Diagnostics|IMDX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal imdxinc.com|IMDX - Gunggung kewajiban utang perusahaan|Utang-utang marang kapitalisasi buku Insight Molecular|IMDX - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Insight Molecular Diagnostics|Indikator likuiditas cepet imdxinc.com
- indikator bathi lan kelipatan valuasi:
IMDX - Bathi sawise mbayar pajeg|Bathi mangsa ngarep Insight Molecular Diagnostics|IMDX - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep imdxinc.com|IMDX - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Insight Molecular|IMDX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Insight Molecular Diagnostics|IMDX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan imdxinc.com|IMDX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Insight Molecular Diagnostics
Analisis kabeh metrik perusahaan:Insight Molecular Diagnostics, Inc. - IMDX
This indicator measures the quarterly dynamics of net earnings per share, allowing for an assessment of capital resilience against external market shocks. By analyzing the percentage change in quarterly EPS, an investor determines the extent to which biomarker patent protection and high CLIA certification barriers translate into real profitability growth for Insight Molecular Diagnostics (IMDX) relative to operating expenses.
Pesaing Insight Molecular Diagnostics
A: Wutah bathi EPS kuartalan|DGX - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Illumina Corp|Exact Sciences Inc. (EXAS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan RVTY|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan bio-rad.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Anbio NNNN|SHC: Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|QDEL - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan OPKO Health Corp. OPK|CDNA: Wutah bathi EPS kuartalan|MRVI - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|FLGT (Fulgent Genetics) - Wutah bathi EPS kuartalan|LAB - Wutah bathi resik saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan CTKB|OSUR (OraSure Corp) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Exagen - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MDXH (mdxhealth.com)|LUCD: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan PRE (Prenetics Global)|trinitybiotech.com (TRIB) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ProPhase Labs Corp|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Ainos, Inc.|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan codiagnostics.com CODX|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan HeartSciences (HSCS)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BMRA (Biomerica Inc.)|Wutah bathi EPS kuartalan CDIO (Cardio Diagnostics Holdings)|Onconetix Corporation (ONCO) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Virax Biolabs Group - Wutah bathi EPS kuartalan|bluejaydx.com (BJDX) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|AWH (Aspira Women's Health Inc.) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Accelerate Diagnostics Inc. (AXDX) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan CENTOGENE|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ENZ|Wutah bathi EPS kuartalan FRES|Wutah bathi EPS kuartalan gtglabs.com (GENE)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan 23andMe ME|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan PMD
